1. Home
  2. MFM vs CDXS Comparison

MFM vs CDXS Comparison

Compare MFM & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFS Municipal Income Trust

MFM

MFS Municipal Income Trust

HOLD

Current Price

$5.33

Market Cap

219.3M

Sector

Finance

ML Signal

HOLD

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$2.49

Market Cap

256.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MFM
CDXS
Founded
1986
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Major Chemicals
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
219.3M
256.3M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
MFM
CDXS
Price
$5.33
$2.49
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
125.7K
1.1M
Earning Date
01-01-0001
05-07-2026
Dividend Yield
4.08%
N/A
EPS Growth
N/A
43.82
EPS
0.03
N/A
Revenue
N/A
$138,590,000.00
Revenue This Year
N/A
$7.73
Revenue Next Year
N/A
$14.24
P/E Ratio
$177.50
N/A
Revenue Growth
N/A
32.30
52 Week Low
$5.03
$0.96
52 Week High
$5.67
$3.87

Technical Indicators

Market Signals
Indicator
MFM
CDXS
Relative Strength Index (RSI) 39.94 50.12
Support Level $5.23 $2.40
Resistance Level $5.48 $2.67
Average True Range (ATR) 0.05 0.21
MACD -0.02 -0.05
Stochastic Oscillator 14.29 21.43

Price Performance

Historical Comparison
MFM
CDXS

About MFM MFS Municipal Income Trust

MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but it may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.

About CDXS Codexis Inc.

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: